PID Facilities in India

Size: px
Start display at page:

Download "PID Facilities in India"

Transcription

1 PID Facilities in India Natinal Institute f Immunhematlgy (ICMR) 13 th Flr, NMS Building KEM Hspital Campus, Parel, Mumbai. Website: Resurce persn: 1. Dr. Manisha Madkaikar Directr-in-charge, Scientist E manishamanisha@yah.c.in Diagnstic facilities available: Primary Immundeficiency Screening: Serum Immunglbulin estimatin IgG, A, M, E - Nephelmetry-based assays Lymphcyte subset analysis: T, B and NK cells enumeratin - Flwcytmetry Activatin markers : CD25, HLA-DR - Flwcytmetry Nitrblue tetrazlium bld test - Micrscpy Severe Cmbined Immundeficiency (SCID) wrkup: Lymphcyte subset analysis: T, B and NK - Flwcytmetry T - B + NK - : CD132 (cmmn γ chain fr X- linked SCID), pstat5 - Flwcytmetry T - B + NK +: CD127 (IL7Rα)- Flwcytmetry and Mlecular study T - B - NK - : ADA - Spectrphtmeter and Mlecular study T - B - NK + : RAG1/ RAG2 gene - Mlecular study MHC class II deficiency(cd4 lymphpenia) : HLA DR expressin - Flwcytmetry Very lw CD8: CD8 α Expressin - Flwcytmetry CD8 lymphpenia: ZAP70 gene - Mlecular study

2 Chrnic Granulmatus Disease (CGD) wrkup: Nitrblue tetrazlium bld test - Micrscpy Dihydrrhdamine assay (DHR)- Flwcytmetry Autsmal recessive: p47phx, p67 phx(intracellular antigens) - Flwcytmetry CYBB, gene NCF1 gene, NCF2 gene - Mlecular study X linked 7 D5 expressin (gp91phx/p22phx) - Flwcytmetry CYBB gene - Mlecular study Hemphagcytic Lymphhisticytsis (HLH) wrkup: Perfrin and Granzyme B n NK cells and Tc cells - Flwcytmetry NK cell cyttxicity and Granule release assay- Flwcytmetry Perfrin gene (FHL2), MUNC 13-4 gene (FHL3), STX 11 gene (FHL4)- Mlecular study IL6, IL10, Ferritin, scd25, TNFα - ELISA Leukcyte Adhesin Deficiency-I (LAD- I): CD18, CD11a, CD11b, CD11c- Flwcytmetry ITBG2 (β2 integrin gene) - Mlecular study Autimmune Lymphprliferative Syndrme (ALPS) wrk up Lymphcyte subset analysis: T, B and NK- Flwcytmetry Duble negative T cells (CD3, TCRαβ, CD4, and CD8) - Flwcytmetry Apptsis assay- Flwcytmetry FAS ligand and Vit B 12 -ELISA FAS gene -Mlecular study BENTA (B-cell expansin with NF-jB and T-cell anergy) Wrkup Lymphcyte subset analysis: T, B and NK- Flwcytmetry B cell immunphentyping- Flwcytmetry Naïve and Memry B cells Switched and Unswitched B cells Switched and Unswitched memry B cells Transitinal cells Serum Immunglbulin estimatin IgG, A, M, E- Nephelmetry-based assays CARD11 gene - Mlecular study

3 Mendelian Susceptibility t Mycbacterial Diseases (MSMD) wrkup: Lymphcyte subset analysis: T, B and NK- Flwcytmetry Hyper IgM syndrme Nitrblue tetrazlium bld test -Micrscpy IFNγR1, IFNγR2 and IL-12Rβ1 expressin- Flwcytmetry pstat1, pstat4- Flwcytmetry IFNγ and IL-12P40 - ELISA IFNγR1 gene- Mlecular study Autsmal recessive: X linked CD40 expressin- Flwcytmetry CD40 gene Mlecular study Serum Immunglbulin estimatin IgG, A, M, E-Nephelmetry-based assays CD40L expressin n activated T cells Flwcytmetry CD40L gene Mlecular study Serum Immunglbulin estimatin IgG, A, M, E-Nephelmetry-based assays X-linked agammaglbulinemia (XLA) wrkup Lymphcyte subset analysis: T, B and NK- Flwcytmetry CD20 expressin- Flwcytmetry Btk expressin n mncytes- Flwcytmetry Serum Immunglbulin estimatin IgG, A, M, E -Nephelmetry-based assays

4 PID Facilities in India Bai Jerbai Wadia Hspital fr Children, Mumbai Website: Resurce persn: Dr. Mukesh Desai Hn. Hematlgist Onclgist & Immunlgist. Prf. f Pediatric Hematlgy Onclgy (DNB) Department f PHO. Chief Divisin f Immunlgy. B. J. Wadia Hspital fr Children. Cell: Tel: / Etxn mmdesai007@gmail.cm URL: URL: Mr. Prasad D. Taur Junir Scientific Officer Cell: prasadtaur@gmail.cm Bai Jerbai Wadia Hspital fr Children, Mumbai acts as a tertiary referral centre in and arund Maharashtra. Dr. Zinet Currimbhy funded the Divisin f Immunlgy at B.J. Wadia Hspital fr Children. She evlved a cllabrative apprach with NIIH that established the investigatin fr Primary Immundeficiency and Divisin f Immunlgy, B.J. Wadia Hspital, which run the clinical services. The Divisin f Immunlgy has its ut patients services n every Thursday in OPD n. 6 since 4 th OCT 2007 at Bai Jerbai Wadia Hspital fr Children, Parel, Mumbai. It als caters fr ambulatry and Indr care f Children with Primary Immundeficiency Disrders (PID).

5 The Divisin f Immunlgy has a pst f Medical Research Officer called as Currimbhy Schlar having remuneratin f 12000/- per mnth. The Divisin f Immunlgy has Mr. Prasad Taur appinted as Junir Scientific Officer. The wrk is carried ut at ur Divisin f Immunlgy and at Natinal Institute f Immunhaematlgy (NIIH), ICMR as per liaisn established with them. Facilities: Immunlgy OPD: Thursday 10:00 am t 12:00 am in OPD n.6 Immunlgy Case Discussin: Mnday 11:30 1:00 pm New Immunlgy referrals: Accepted between 9am t 4 pm between Mnday t Saturday Indr Service: Indr patients frm Medical, Surgical units and Intensive Care areas were being catered t by the Divisin f Immunlgy n a daily basis. The Divisin f Immunlgy has cllabratin in varius nging prjects n different cards f Primary Immundeficiency with Natinal Institute f Immunhaematlgy (NIIH), Entervirus Research Centre (EVRC), ICMR.

Consensus Recommendations for the Management of Chronic Lymphocytic Leukemia: Primary Care Guideline

Consensus Recommendations for the Management of Chronic Lymphocytic Leukemia: Primary Care Guideline Practice Guideline: Clinical Guide Cnsensus Recmmendatins fr the Management f Chrnic Lymphcytic Leukemia: Primary Care Guideline CCMB Practice Guideline Clinical Guide Develped by: Lymphprliferative Disrders

More information

What Should One Know About Thalassaemia Minor

What Should One Know About Thalassaemia Minor What Shuld One Knw Abut Thalassaemia Minr What Is Thalassaemia? Thalassaemia is a cmmn inherited genetic disrder f hemglbin (Hb). T understand Thalassaemia ne shuld knw a bit mre abut Hb and its Structure

More information

Evaluation of Hunter & New England HealthPathways

Evaluation of Hunter & New England HealthPathways Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%

More information

Request for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax

Request for Prior Authorization for Click here to enter text. Website Form   Submit request via: Fax Request fr Prir Authrizatin fr Click here t enter text. Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 Updated: 05/2018 DMMA Apprved: 05/2018 All requests fr Intravenus

More information

Directorate of Laboratory Medicine

Directorate of Laboratory Medicine Directrate f Labratry Medicine Presenting The Clinical Sciences Labratry Centre Prviding a mdern cmprehensive Pathlgy Service fr the ppulatins f Greater Manchester and beynd Clinical Sciences Building

More information

Table of Contents. Introduction Autoimmune Lymphoproliferative Syndrome Absolute T Bruton s Tyrosine Kinase...

Table of Contents. Introduction Autoimmune Lymphoproliferative Syndrome Absolute T Bruton s Tyrosine Kinase... Table of Contents Introduction... 2 Autoimmune Lymphoproliferative Syndrome... 3 Absolute T4... 4 Bruton s Tyrosine Kinase... 5 Common Variable Immunodeficiency... 6 Cytotoxicity/Apoptosis... 7 Hyper IgM...

More information

Responsible Document # Topic

Responsible Document # Topic NYP/Q DSRIP PPS PC / BH Integratin Cmmittee Meeting Title: Facilitatr(s): Lcatin: NYP/Q DSRIP Primary Care / Behaviral Health Integratin Prject Meeting Date: Meeting M. D Urs, RN Time: NYPQ 56-45 Main

More information

Defects of Innate Immunity

Defects of Innate Immunity Defects of Innate Immunity TLR signalling IRAK4 and MyD88 AR Same clinical phenotype for both genes (Recurrent) invasive bacterial infections: Meningitis and septicemia >> skin Pneumococcus >> Staph aureus

More information

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009 T Cell Activation Patricia Fitzgerald-Bocarsly March 18, 2009 Phases of Adaptive Immune Responses Phases of T cell responses IL-2 acts as an autocrine growth factor Fig. 11-11 Clonal Expansion of T cells

More information

CLL Updated February 2016 by Dr. Manna (PGY 5 Hematology Resident, University of Calgary)

CLL Updated February 2016 by Dr. Manna (PGY 5 Hematology Resident, University of Calgary) CLL Updated February 2016 by Dr. Manna (PGY 5 Hematlgy Resident, University f Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematlgist, University f Calgary) and Dr. Matt Cheung (Staff Hematlgist, University

More information

AP Biology Immune System. Pathogens: agents that cause disease Immunity: the ability to avoid disease when invaded by a pathogen

AP Biology Immune System. Pathogens: agents that cause disease Immunity: the ability to avoid disease when invaded by a pathogen AP Bilgy Pathgens: agents that cause disease Immunity: the ability t avid disease when invaded by a pathgen Innate Immunity: nnspecific First line f defense Barriers such as skin Hard fr bacteria t penetrate

More information

APA-accredited: YES NO X. Brown University. Stephen Salloway, M.D. (Primary Supervisor) Paul Malloy, Ph.D.

APA-accredited: YES NO X. Brown University. Stephen Salloway, M.D. (Primary Supervisor) Paul Malloy, Ph.D. Clinical Psychlgy Training Prgrams at Brwn: A Cnsrtium f the Prvidence VA Medical Center, Lifespan, and Care New England Pstdctral Fellwship Training Prgram Pstdctral Fellwship Descriptin: RESEARCH FOCUS

More information

23/10/2017. Diagnosis and Monitoring of Primary Immunodeficiencies. What are Primary Immunodeficiencies? How do we organize them???

23/10/2017. Diagnosis and Monitoring of Primary Immunodeficiencies. What are Primary Immunodeficiencies? How do we organize them??? Diagnosis and Monitoring of Primary Immunodeficiencies Marianna Tzanoudaki, MD PhD Department of Immunology & Histocompatibility, Specialized Referral Centre for Primary Immunodeficiencies - Paediatric

More information

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin

More information

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child. Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet

More information

Oral Surgery (Facial Pain) Service Specification

Oral Surgery (Facial Pain) Service Specification Oral Surgery (Facial Pain) Service Specificatin Service Cmmissiner Lead Prvider Lead Perid 2. Oral Surgery Facial Pain (SBCH Ref N. SS_046) 1. Purpse 1.1 Aims T prvide a Cnsultant-led specialist diagnstic,

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care. Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,

More information

Antigen-Independent B-Cell Development Bone Marrow

Antigen-Independent B-Cell Development Bone Marrow Antigen-Independent B-Cell Development Bone Marrow 1. DNA rearrangements establish the primary repertoire, creating diversity 2. Allelic exclusion ensures that each clone expresses a single antibody on

More information

COPD Outreach Program

COPD Outreach Program COPD Outreach Prgram Wendy Laframbise, Advanced Practice Nurse Certified Respiratry Educatr COPD Outreach Prgram March, 2015 Disclaimer: The Canadian Fundatin fr Healthcare Imprvement (CFHI), in partnership

More information

New London County Unified Intake for Homeless Families

New London County Unified Intake for Homeless Families New Lndn Cunty Unified Intake fr Hmeless Families Presentatin by Lisa Tepper Bates, Executive Directr Mystic Area Shelter & Hspitality (MASH) 2011 Snapsht: Family Hmelessness in Sutheastern CT Frm 2010

More information

Chapter 19: IgE-Dependent Immune Responses and Allergic Disease

Chapter 19: IgE-Dependent Immune Responses and Allergic Disease Allergy and Immunology Review Corner: Chapter 19 of Cellular and Molecular Immunology (Seventh Edition), by Abul K. Abbas, Andrew H. Lichtman and Shiv Pillai. Chapter 19: IgE-Dependent Immune Responses

More information

κ λ Antigen-Independent B-Cell Development Bone Marrow Ordered Rearrangement of Ig Genes During B-Cell Development in the Bone Marrow

κ λ Antigen-Independent B-Cell Development Bone Marrow Ordered Rearrangement of Ig Genes During B-Cell Development in the Bone Marrow Antigen-Independent B-Cell Development Bone Marrow 1. DNA rearrangements establish the primary repertoire, creating diversity 2. Allelic exclusion ensures that each clone expresses a single antibody on

More information

Introduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65)

Introduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65) Intrductin t Psychlgical Disrders (Myers fr AP 2 nd Editin, Mdule 65) Why are we s interested in learning abut psychlgical disrders? The Wrld Health Organizatin reprts that peple suffer frm mental r behavir

More information

Neonatal screening for PID. T cell defects (SCID) B cell defects (XLA) Phagocytic disorders (CGD) Complement defects (C2, P)

Neonatal screening for PID. T cell defects (SCID) B cell defects (XLA) Phagocytic disorders (CGD) Complement defects (C2, P) Lennart Hammarström Stephan Borte Ulrika von Döbeln Clinical Immunology Karolinska Institutet at KUS Huddinge γc JAK 3 Pro NK Periphery NK Common lymphoid progenitors Haematopoetic stem cells γc JAK 3

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

AVAILABLE BIOMARKER ASSAYS

AVAILABLE BIOMARKER ASSAYS AAILABLE BIOMARKER ASSAYS alidation Alpha-2-microglobulin ELISA Anti-CD71/anti-platelet/propidium iodide Anti-KLH IgG ELISA,, Dog, Minipig, Apoptotic, necrotic and dead cells (bone marrow) B (activated

More information

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Γ. Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.Α The nrmal pericardium is

More information

Lyme Disease Surveillance in North Carolina

Lyme Disease Surveillance in North Carolina Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014

More information

IMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS

IMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS LECTURE: 07 Title: IMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS LEARNING OBJECTIVES: The student should be able to: The chemical nature of the cellular surface receptors. Define the location of the

More information

(PRIMARY) IMMUNE DEFICIENCIES

(PRIMARY) IMMUNE DEFICIENCIES Neil Romberg MD UPENN/Perelman SOM Children s Hospital of Philadelphia Division of Immunology and Allergy (PRIMARY) IMMUNE DEFICIENCIES immunity is nearly invisible immunity is nearly invisible, unless

More information

Creating Models to Drive Interprofessional Education and Practice

Creating Models to Drive Interprofessional Education and Practice Creating Mdels t Drive Interprfessinal Educatin and Practice Tara A. Crtes, PhD, RN, FAAN Executive Directr, Hartfrd Institute fr Geriatric Nursing Prfessr, NYU Rry Meyers Cllege f Nursing June 8, 2017

More information

ALLERGY. The effect of alternate-day prednisone on the white blood count in children with chronic asthma

ALLERGY. The effect of alternate-day prednisone on the white blood count in children with chronic asthma The Jurnal f ALLERGY and CLINICAL IMMUNOLOGY VOLUME 51 NUMBER 2 The effect f alternate-day prednisne n the white bld cunt in children with chrnic asthma H. Cha, M.D., and A. Gilbert, M.T. Denver, Cl. Children

More information

Essentials of Blood Pressure Management Session 5: Blood Pressure, Kidneys and Complications

Essentials of Blood Pressure Management Session 5: Blood Pressure, Kidneys and Complications Kidney and HTN: Tw Beans in a Pd will begin at 12:00 PM ET Dwnlad sessin materials and view archived sessins at http://bit.ly/ufbpwebpage Add Flavr and Imprve Nutritin with Fresh Herbs Thursday, July 12

More information

Palliative Medicine Specialist

Palliative Medicine Specialist Date: June 2017 Jb Title : Palliative Medicine Specialist Department : Palliative Care Services, Specialty Medicine & Health f Older Peple Divisin Lcatin : Nrth Shre Hspital primarily, althugh there may

More information

Venom Hypersensitivity

Venom Hypersensitivity Venm Hypersensitivity Venm Allergy Large lcalised reactin ~ 10% in adults Systemic allergic reactins Up t 3% f adults Severe sting reactins in up t 1% f children In Australia, apprximately 2 fatalities

More information

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Rituxan (rituximab) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Effective Date: 10/01/2015 POLICY A. INDICATIONS The indicatins belw including FDA-apprved indicatins and cmpendial uses

More information

Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party

Voting feature in App. Breaks Optional Event Educational Session Meet the expert INGID Working Party TIMETABLE Plenary Workshop Special Breaks Optional Event Educational Meet the expert INGID Working Party Wednesday 24 October 2018 I 08:30-09:00 Educational Lecture - Lymphoproliferation in PIDs 09:00-09:30

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

Attachment 3. Efforts to Address the Opioid Epidemic in Clark County

Attachment 3. Efforts to Address the Opioid Epidemic in Clark County Attachment 3 Effrts t Address the Opiid Epidemic in Clark Cunty Overview Backgrund Current wrk SNHD Challenges Next Steps Backgrund Drug verdses are nw the leading cause f death amng Americans under 50

More information

The Adaptive Immune Responses

The Adaptive Immune Responses The Adaptive Immune Responses The two arms of the immune responses are; 1) the cell mediated, and 2) the humoral responses. In this chapter we will discuss the two responses in detail and we will start

More information

Laboratory evaluation of primary immunodeficiencies. Kaspar René Nielsen Dept. Of Clinical Immunology And Transfusion Medicine

Laboratory evaluation of primary immunodeficiencies. Kaspar René Nielsen Dept. Of Clinical Immunology And Transfusion Medicine Laboratory evaluation of primary immunodeficiencies Kaspar René Nielsen Dept. Of Clinical Immunology And Transfusion Medicine More than 200 primary immunodeficeincies (PID) have been described Cant A.

More information

Young Hackney Substance Misuse Service

Young Hackney Substance Misuse Service Yung Hackney Substance Misuse Service Needs Assessment The Needs Assessment carried ut in 2014 highlighted the fllwing key areas fr imprvement and develpment: Lack f existing service prvisin fr 19 25 year

More information

Primary Health Networks Greater Choice for At Home Palliative Care Central Queensland Wide Bay Sunshine Coast PHN

Primary Health Networks Greater Choice for At Home Palliative Care Central Queensland Wide Bay Sunshine Coast PHN Primary Health Netwrks Greater Chice fr At Hme Palliative Care Central Queensland Wide Bay Sunshine Cast PHN Dcument cntrl 1 1. Planned activities funded under the Activity Primary Health Netwrks Greater

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Figure 1. NKT ligand-loaded tumour antigen-presenting B cell- and monocyte-based vaccine induces NKT, NK and CD8 T cell responses. (A) The cytokine profiles of liver

More information

IMMUNODEFICIENCIES CLASSIFICATION OF PIDS PRIMARY IMMUNODEFICIENCIES CLASSIFIED?

IMMUNODEFICIENCIES CLASSIFICATION OF PIDS PRIMARY IMMUNODEFICIENCIES CLASSIFIED? PRIMARY IMMUNODEFICIENCIES CLASSIFICATION OF PIDS HOW ARE PRIMARY IMMUNODEFICIENCIES CLASSIFIED? 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS CGD CVID IBD IgA/D/E/G/M IPOPI PID SCID Chronic granulomatous

More information

Case Presentations in Primary Immune Deficiency Diseases. John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL

Case Presentations in Primary Immune Deficiency Diseases. John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL Case Presentations in Primary Immune Deficiency Diseases John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL COPD and recurrent infections 42 WF non- smoker with diagnosis

More information

Field Epidemiology Training Program

Field Epidemiology Training Program Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE FETP Cancer Curriculum: Principles f Cancer Registries Case

More information

CALIFORNIA NEWBORN SCREENING FOR SCID. Joseph A. Church, M.D. Children s Hospital Los Angeles and Keck School of Medicine at U.S.C.

CALIFORNIA NEWBORN SCREENING FOR SCID. Joseph A. Church, M.D. Children s Hospital Los Angeles and Keck School of Medicine at U.S.C. CALIFORNIA NEWBORN SCREENING FOR SCID Joseph A. Church, M.D. Children s Hospital Los Angeles and Keck School of Medicine at U.S.C. CELLS, DNA AND GENES HOW GENES GO WRONG - MUTATIONS MONOGENIC TRAIT: Determined

More information

3. Cancer Vanguard. 4. Feedback from leads gap analysis, stratified follow up. London Cancer Gynaecological Cancer Pathway Board

3. Cancer Vanguard. 4. Feedback from leads gap analysis, stratified follow up. London Cancer Gynaecological Cancer Pathway Board Lndn Cancer Gynaeclgical Cancer Pathway Bard Date: Tuesday, 17 th January 2017, 16:00 18:00 Venue: Bardrm, UCLH Westmreland Street Hspital, 16-18 Westmreland St, Lndn W1G 8PH Chair: Tim Muld, Pathway Directr

More information

TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE

TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE Sunday 19 July, 2015 TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE SIX STRATEGIC pririties have tday (Sunday) been recmmended by the Independent Cancer Taskfrce t help

More information

SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY

SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY Sme 50% f cancers that affect wmen are lcated in the breast r in the genital rgans. Gynaeclgical

More information

Andrea s Final Exam Review PCB 3233 Spring Practice Final Exam

Andrea s Final Exam Review PCB 3233 Spring Practice Final Exam NOTE: Practice Final Exam Although I am posting the answer key for this practice exam, I want you to use this practice to gauge your knowledge, and try to figure out the right answer by yourself before

More information

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 13 Effector Responses: Cell- and Antibody-Mediated Immunity Copyright 2013 by W. H.

More information

Annual Report

Annual Report Immune Deficiency Fundatin f Australia Raising awareness & supprting peple affected by immune deficiencies in Australia Annual Reprt 2016-2017 Christine Jeffery, Executive Officer Immune Deficiencies Fundatin

More information

Pregnant Patient Report

Pregnant Patient Report 8-8-16 (~16 weeks pregnant) 7-26-16 screening panel (~14 weeks pregnant) 7-6-16 screening panel (~11 weeks pregnant) 6-1-16 (~5.5 weeks pregnant) 9-15-15 (not pregnant) Complete HLA analysis added 1-31-14

More information

Syed E Maududi, MD Cell Phone: (847) Address:

Syed E Maududi, MD Cell Phone: (847) Address: Syed E Maududi, MD Cell Phne: (847) 970-1056 Email Address: Syed.Maududi@dwnstate.edu CAREER SUMMARY Experienced and perfrmance riented ECFMG Certified Psychiatrist with > 4 years f experience (residency

More information

Technical Bulletin No. 132

Technical Bulletin No. 132 CPAL Central Pennsylvania Alliance Labratry Technical Bulletin N. 132 Octber 31, 2014 Methd and Panel Cmpnents Change fr Flw Cytmetry Immunphentyping fr Leukemia and Lymphma (FCI) Starting Date: Nvember

More information

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties

More information

STANDARD OPERATING PROCEDURES (SOP) EXPANDING THE CONTINUUM OF CARE SATELLITE SITES

STANDARD OPERATING PROCEDURES (SOP) EXPANDING THE CONTINUUM OF CARE SATELLITE SITES STANDARD OPERATING PROCEDURES (SOP) EXPANDING THE CONTINUUM OF CARE SATELLITE SITES 1. Intrductin t Cntinuum f Care In 2003, the Ministry f Health f the Ryal Kingdm f Cambdia apprved the Cntinuum f Care

More information

T-cells. Monika Raulf. T-cell-mediated immunity T-cell regulation T-cell development

T-cells. Monika Raulf. T-cell-mediated immunity T-cell regulation T-cell development T-cells Monika Raulf T-cell-mediated immunity T-cell regulation T-cell development Lecture 02.05.2018 Stimulation of the T-cells by an antigenpresenting cell Antigen 1. Signal T-Lymphocyte TCR MHC+ Peptide

More information

Data Fusion for Predicting Breast Cancer Survival

Data Fusion for Predicting Breast Cancer Survival Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current

More information

Development of Automation in Semen Analysis

Development of Automation in Semen Analysis Develpment f Autmatin in Semen Analysis Matt Tmlinsn PhD Cnsultant Scientist in Reprductin Nttingham University Hspital University f Nttingham Msc Assisted Reprductin Scientific Directr Prcreative Diagnstics

More information

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information

INBORN ERRORS OF METABOLISM (IEM) A GENERAL OVERVIEW

INBORN ERRORS OF METABOLISM (IEM) A GENERAL OVERVIEW INBORN ERRORS OF METABOLISM (IEM) A GENERAL OVERVIEW Backgrund 1. General Infrmatin Classificatin Traditinaly IEM have been classified accrding t the type f metablism invlved. (nte Purine & Pyrimidine

More information

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group FIT Board Review Corner September 2015 Welcome to the FIT Board Review Corner, prepared by Andrew Nickels, MD, and Sarah Spriet, DO, senior and junior representatives of ACAAI's Fellows-In-Training (FITs)

More information

ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY

ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY The recognition of specific antigen by naïve T cell induces its own activation and effector phases. T helper cells recognize peptide antigens through

More information

Primary Immunodeficiency

Primary Immunodeficiency Primary Immunodeficiency DiGeorge Syndrome Severe Combined Immunodeficiency SCID X-Linked Agammaglobulinemia Common variable immunodeficiency (CVID) IgA deficiency Hyper- IgM Syndrome Wiskott-Aldrich syndrome

More information

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57 Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical

More information

Mental Health Promotion in Gambia

Mental Health Promotion in Gambia Mental Health Prmtin in Gambia 2013-2015 A very little abut Mbee Mbee = Everyne in Mandinka language T raise awareness f the imprtance f Mental wellbeing in the Gambia in partnership with AFG and Natinal

More information

T cell and Cell-mediated immunity

T cell and Cell-mediated immunity T cell and Cell-mediated immunity Lu Linrong ( 鲁林荣 ) PhD Laboratory of Immune Regulation Institute of Immunology Zhejiang University, it School of Medicine i Medical Research Building B815-819 Email: Lu.Linrong@gmail.com

More information

Overview. Individuals with Foxp1-related disorder A mouse model for Foxp1-related disorder syndrome Stem cells in Foxp1-related disorder

Overview. Individuals with Foxp1-related disorder A mouse model for Foxp1-related disorder syndrome Stem cells in Foxp1-related disorder Fxp1 Syndrme Jseph D Buxbaum, PhD Directr, Seaver Autism Center Deputy Chair, Department f Psychiatry Icahn Schl f Medicine at Munt Sinai www.seaverautismcenter.rg Overview Individuals with Fxp1-related

More information

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii Ringworm fungus HIV Influenza Candida Staph aureus Mycobacterium tuberculosis Listeria Salmonella Streptococcus Levels

More information

Meeting of the London Cancer Radiotherapy Expert Reference Group Date: Monday 2 nd October 2017, 15:30-17:00

Meeting of the London Cancer Radiotherapy Expert Reference Group Date: Monday 2 nd October 2017, 15:30-17:00 Meeting f the Lndn Cancer Raditherapy Expert Reference Grup Date: Mnday 2 nd Octber 2017, 15:30-17:00 Venue: 6 th flr West Meeting Rm, 250 Eustn Rad, Lndn, NW1 2PG Chair: Anna Thmpsn 1. Welcme, intrductins,

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Smoking Cessation Improvement in SFHN Primary Care,

Smoking Cessation Improvement in SFHN Primary Care, Smking Cessatin Imprvement in SFHN Primary Care, 2015-16 David Silven, PhD, Supervising Psychlgist, SFHN Primary Care Behaviral Health Ellen Chen, MD, Directr f Quality, SFHN Primary Care Why smking assessment

More information

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1 State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan

More information

Immunology. Antibodies for immunology research

Immunology. Antibodies for immunology research Immunology Antibodies for immunology research antibodies for immunology research BP0169 BP0003-1 BP0004-1 BP0061 CD4 + T cells Control LOB12.3 Relative Cell Number CD4 (55 kda) CD8α (35 kda) CD8α (35 kda)

More information

Memory Screening Site s PROGRAM HANDBOOK

Memory Screening Site s PROGRAM HANDBOOK Memry Screening Site s PROGRAM HANDBOOK 866-232-8484 www.alzfdn.rg/memry-screening/ Table f Cntents Page 3 Page 5 Page 6 Page 7 Page 8 Page 10 Page 12 Page 13 All Abut the Natinal Memry Screening Prgram

More information

VCCC Research and Education Lead for Breast Cancer

VCCC Research and Education Lead for Breast Cancer VCCC Research & Educatin Lead VCCC Research and Educatin Lead fr VCCC Visin The Victrian Cmprehensive Cancer Centre (VCCC) will save lives thrugh the integratin f cancer research, educatin and clinical

More information

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters, Immunology T-Lymphocytes 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters, karin.peters@rub.de The role of T-effector cells in the immune response against microbes cellular immunity humoral immunity

More information

Using discussion and case examples, and specific approaches that attendees can immediately use the presenters will extend and enhance skill with:

Using discussion and case examples, and specific approaches that attendees can immediately use the presenters will extend and enhance skill with: This seminar is based n: published material Drs. Curtis and Frd their jint wrk as c-chairs f the Internatinal Sciety fr Traumatic Stress Studies Cmplex Trauma Task Frce and its recently published treatment

More information

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214, Adaptive Immunity Jeffrey K. Actor, Ph.D. MSB 2.214, 500-5344 Lecture Objectives: Understand role of various molecules including cytokines, chemokines, costimulatory and adhesion molecules in the development

More information

Immunological Tolerance

Immunological Tolerance Immunological Tolerance Introduction Definition: Unresponsiveness to an antigen that is induced by exposure to that antigen Tolerogen = tolerogenic antigen = antigen that induces tolerance Important for

More information

Strategic Plan Publication No: EO-SP

Strategic Plan Publication No: EO-SP Strategic Plan 2017-2019 Publicatin N: EO-SP-170223 +61 2 9036 5002 www.pcg.rg.au pcg.ffice@sydney.edu.au This dcument was prepared by the PCG Executive Office PCG Publicatin number: EO-SP-170223 Psych-nclgy

More information

Appendix Cancer / PMP Research Foundation. PMP Pals Conference October 9, 2016

Appendix Cancer / PMP Research Foundation. PMP Pals Conference October 9, 2016 Appendix Cancer / PMP Research Fundatin PMP Pals Cnference Octber 9, 2016 What d we d? ACPMP is dedicated t 1) funding research t find a cure fr PMP, Appendix Cancer, and related Peritneal Surface Malignancies

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD- Supplementary Methods Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD- L1 (10F.9G2, rat IgG2b, k), and PD-L2 (3.2, mouse IgG1) have been described (24). Anti-CTLA-4 (clone

More information

Widening of funding restrictions for rituximab and eltrombopag

Widening of funding restrictions for rituximab and eltrombopag 20 February 2014 Widening f funding restrictins fr rituximab and eltrmbpag PHARMAC is pleased t annunce the apprval f prpsals t widen the restrictin n rituximab use in DHB hspitals and expand the funding

More information

T cell maturation. T-cell Maturation. What allows T cell maturation?

T cell maturation. T-cell Maturation. What allows T cell maturation? T-cell Maturation What allows T cell maturation? Direct contact with thymic epithelial cells Influence of thymic hormones Growth factors (cytokines, CSF) T cell maturation T cell progenitor DN DP SP 2ry

More information

CARDIOLOGY Referral Guidance Sheet

CARDIOLOGY Referral Guidance Sheet Tyren, 3 heart transplant CARDIOLOGY I wish t be a fireman DEAR CARDIOLOGY HEALTH CARE PROFESSIONAL, USUALLY QUALIFYING CARDIOLOGY CONDITIONS: Cmplex cngenital heart disease, such as: Single ventricle

More information

18 th Annual Citi Not-for-Profit Health Care Investor Conference. Managing Change

18 th Annual Citi Not-for-Profit Health Care Investor Conference. Managing Change 18 th Annual Citi Nt-fr-Prfit Health Care Investr Cnference Managing Change May 24, 2017 Presenters: Richard P. Miller President and Chief Executive Officer Rbert M. Segin Executive Vice President and

More information

Belgian Volition SA - a VolitionRx Company- Technological company presentation BIOWIN DAY 2014

Belgian Volition SA - a VolitionRx Company- Technological company presentation BIOWIN DAY 2014 Belgian Vlitin SA - a VlitinRx Cmpany- Technlgical cmpany presentatin BIOWIN DAY 2014 Abut VlitinRx Wh we are Lab and Head ffice in Namur, Belgium Creatin: Oct 2010 8 emplyees + Internatinal Bard f Directrs

More information

Immunodeficiency. (1 of 2)

Immunodeficiency. (1 of 2) Immunodeficiency (1 of 2) Primary immunodeficiency diseases Innate or adaptive Most are detected in infancy (6 months 2 years) Rare but some mild genetic forms exist in many individuals Defects in Innate

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information

A. Catalonia World Health Organization Demonstration Project

A. Catalonia World Health Organization Demonstration Project A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin

More information

PANDERIA: WHEN PANDEMIC LEADS TO PANIC

PANDERIA: WHEN PANDEMIC LEADS TO PANIC INGSA CASE STUDIES PANDERIA: WHEN PANDEMIC LEADS TO PANIC Tatjana Buklijas (INGSA/University f Auckland). 1 PANDERIA WHEN PANDEMIC LEADS TO PANIC A new highly cntagius viral disease, labelled Frest Respiratry

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable Medical Benefit x Effective: 5/1/18 Pharmacy- Frmulary 1 x Next Review: 6/18 Pharmacy- Frmulary 2 x Date f Origin: 11/07 Immune Glbulins Intravenus: Carimune NF, Flebgamma,

More information